Search research articles
Contact Us
Filters
Showing results (471-480 of 602) with videos related to
Page
of 61
Sort By:
Clinical Neuropharmacology
|
January 18, 2014
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study
Murat Emre, Werner Poewe, Peter Paul De Deyn, et al.
Neurology
|
March 13, 2020
Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire
Carlijn D J M Borm, Femke Visser, Mario Werkmann, et al.
Neurology
|
March 13, 2020
Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder
Alex Iranzo, Ambra Stefani, Aida Niñerola-Baizan, et al.
Journal of Neurology
|
August 20, 2024
Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies
Joaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
BMC Neurology
|
June 27, 2019
Towards seeing the visual impairments in Parkinson's disease: protocol for a multicentre observational, cross-sectional study
Carlijn D J M Borm, Mario Werkmann, Femke Visser, et al.
Journal of Neurology
|
August 1, 2025
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies
Joaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 7, 2011
The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
Anne Pavy-Le Traon, Gerard Amarenco, Susanne Duerr, et al.
Movement Disorders Clinical Practice
|
April 25, 2024
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score
Alessandra Fanciulli, Iva Stankovic, Omer Avraham, et al.
The Lancet. Neurology
|
June 21, 2020
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
Dieter Volc, Werner Poewe, Alexandra Kutzelnigg, et al.
American Journal of Human Genetics
|
November 15, 2016
Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia
Michael Zech, Sylvia Boesch, Esther M Maier, et al.
Page
of 61
Search research articles
Search
Showing results (471-480 of 602) with videos related to
Sort By:
Page
of 61
Clinical Neuropharmacology
|
January 18, 2014
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study
Murat Emre, Werner Poewe, Peter Paul De Deyn, et al.
Neurology
|
March 13, 2020
Seeing ophthalmologic problems in Parkinson disease: Results of a visual impairment questionnaire
Carlijn D J M Borm, Femke Visser, Mario Werkmann, et al.
Neurology
|
March 13, 2020
Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder
Alex Iranzo, Ambra Stefani, Aida Niñerola-Baizan, et al.
Journal of Neurology
|
August 20, 2024
Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies
Joaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
BMC Neurology
|
June 27, 2019
Towards seeing the visual impairments in Parkinson's disease: protocol for a multicentre observational, cross-sectional study
Carlijn D J M Borm, Mario Werkmann, Femke Visser, et al.
Journal of Neurology
|
August 1, 2025
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson's disease: pooled analysis of patient level data from two randomized open-label studies
Joaquim J Ferreira, Jee-Young Lee, Hyeo-Il Ma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 7, 2011
The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
Anne Pavy-Le Traon, Gerard Amarenco, Susanne Duerr, et al.
Movement Disorders Clinical Practice
|
April 25, 2024
Early Screening for the Parkinson Variant of Multiple System Atrophy: A 6-Item Score
Alessandra Fanciulli, Iva Stankovic, Omer Avraham, et al.
The Lancet. Neurology
|
June 21, 2020
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial
Dieter Volc, Werner Poewe, Alexandra Kutzelnigg, et al.
American Journal of Human Genetics
|
November 15, 2016
Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia
Michael Zech, Sylvia Boesch, Esther M Maier, et al.
Page
of 61